Content
04/22/2024
Minneapolis, MN USA
iVEAcare
completed $27.5 million Series A Round funding. Investors include
Vensana Capital (lead), Hatteras Venture Partners, Treo Ventures.
About
iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
